Cargando…
Fournier’s Gangrene under Sodium–Glucose Cotransporter-2 Inhibitors Therapy in Gynecological Patients
Fournier’s gangrene (FG) is a serious pathology of the soft tissues and fascia of the perineum and genital region with a high morbidity and mortality rate. In recent years, the SGLT-2 inhibitor oral antidiabetic has been related to this entity. According to the new warnings from the main drug agenci...
Autores principales: | Serrano Olave, Adriana, Bueno Moral, Ana Isabel, Martínez Bañón, Carmen, González Mesa, Ernesto, Jiménez López, Jesús S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9141785/ https://www.ncbi.nlm.nih.gov/pubmed/35627798 http://dx.doi.org/10.3390/ijerph19106261 |
Ejemplares similares
-
Real-world evidence on sodium-glucose cotransporter-2 inhibitor use and risk of Fournier’s gangrene
por: Yang, Jeff Yufeng, et al.
Publicado: (2020) -
A Rare but Life-Threatening Case of Fournier’s Gangrene Caused by Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor, Empagliflozin
por: Jahir, Tahmina, et al.
Publicado: (2022) -
Fournier Gangrene
por: Wolf, Chelsea T., et al.
Publicado: (2010) -
Fournier’s gangrene
por: Cheung, Phoebe S. Y., et al.
Publicado: (2009) -
Fournier gangrene
por: Parry, Nadiah
Publicado: (2015)